Philip J. Devenish

Partner

迪拜 + 971.4.709.8417

Philip Devenish is a dual-qualified English and Australian trial lawyer who acts as lead counsel and advocate in complex commercial litigation and international arbitration, with a particular focus on contractual disputes and fraud. Over the past decade, he has won or favorably settled more than 95% of his cases.

Philip has secured billions of dollars for global corporations, financial institutions, and sovereign clients in some of the most significant international disputes of the past two decades, as recognized by The American Lawyer and Global Arbitration Review. He has conducted arbitrations under all leading institutional rules and appeared before trial and appellate courts in London, Dubai (DIFC), Sydney, and Brussels.

His landmark victories include a US$1.1 billion damages award against Russia arising from the expropriation of banking investments in Crimea. He defended Saudi Arabia in a US$2 billion dispute arising from the Qatar diplomatic crisis, achieving a "drop hands" settlement with no payment made. He is currently acting in the enforcement of arbitral awards and judgments worth several billion dollars.

Philip is ranked as a Legal 500 UAE "Leading Partner" in Dispute Resolution: Arbitration and International Litigation and is listed in the Legal 500 UK's Arbitration Powerlist of lawyers "deemed the gold standard by businesses." Directories describe him as "the lawyer to go to when facing highly complex cases" (Legal 500 EMEA), with "first rate" cross-examination (Chambers Global) and "advocacy skills that are second to none" (Lexology).

经验

  • German businessman arbitrates ICSID claim against LebanonJones Day is representing German businessman Mr. Abed El Jaouni in ICSID proceedings against Lebanon.
  • Canadian mining company initiates UNCITRAL arbitration against KazakhstanJones Day represents a Canadian mining company in an UNCITRAL arbitration against the Republic of Kazakhstan.
  • Major European electrical grid operator defends against changes of regulated tariffsJones Day is advising a major electrical grid operator and its shareholders, the majority of which are leading investors in energy infrastructure, on bringing claims under the Energy Charter Treaty in arbitration for unforeseeable changes of the system of computing regulated network tariffs which were incompatible with the relevant EU framework and adversely impacted budgets based on legitimate expectations.
  • PTTGC acquires allnex from AdventJones Day advised PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • Major pharmaceutical company arbitrates claims arising out of Chinese investmentsJones Day is representing a major pharmaceutical company in a Hong Kong International Arbitration Centre arbitration arising out of representations and warranties given in respect of the client's investment in a Chinese drug development company whose senior officers and consultants were subsequently prosecuted in the United States for misappropriation of another pharmaceutical company's trade secrets.
  • Clients seek advice in connection with criminal investigation and potential criminal and civil claims relating to alleged fraud of over US$1 billionJones Day is advising clients in connection with a criminal investigation and potential criminal and civil claims relating to an alleged fraud of over US$1 billion.
  • Saudi businessman brings investment arbitration proceedings against Middle Eastern stateJones Day represents a Saudi Arabian businessman in investment arbitration proceedings against a Middle Eastern state.
  • Windoor arbitrates ICSID claim against KazakhstanJones Day is representing Estonian construction company AS Windoor in ICSID arbitration proceedings against the Republic of Kazakhstan.
  • U.S. healthcare company arbitrates ICC claim against Middle Eastern hospital proprietorJones Day is representing a Pittsburgh-based international healthcare management and consulting company in an ICC commercial arbitration against an owner of medical centers and clinics in the Middle East.